CliffBio
small molecule

TRASICOR

OXPRENOLOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRASICOR
Active ingredientOXPRENOLOL HYDROCHLORIDE
Strength20MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1983
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.